Marc Schneider

Prof. Dr. Marc Schneider

Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Saarland, Germany
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Dermato-Endocrinology
Verified
Journal Article
Open access
Marc SchneiderMarc Schneider
Marc Schneider
FSFrank Stracke
Frank Stracke
SHSteffi Hansen
Steffi Hansen
USUlrich F. Schaefer
Ulrich F. Schaefer
The dermal application of drugs is promising due to the ease of application. In this context nano-scale carrier systems were already evaluated in several studies with respect to the skin interactio...

13 May 2011 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
XGXavier Le Guével
Xavier Le Guével
BHBenjamin Hötzer
Benjamin Hötzer
GJGregor Jung
Gregor Jung
KHKlaus Hollemeyer
Klaus Hollemeyer
VTVanessa Trouillet
Vanessa Trouillet
Marc SchneiderMarc Schneider
Marc Schneider

4 June 2020 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
SLSonia M. Lombardo
Sonia M. Lombardo
Marc SchneiderMarc Schneider
Marc Schneider
ATAkif E Türeli
Akif E Türeli
NGNazende Günday-Türeli
Nazende Günday-Türeli
Central nervous system diseases are a heavy burden on society and health care systems. Hence, the delivery of drugs to the brain has gained more and more interest. The brain is protected by the blood–brain barrier (BBB), a selective barrier formed by the endothelial cells of the cerebral microvessels, which at the same time acts as a bottleneck for drug delivery by preventing the vast majority of drugs to reach the brain. To overcome this obstacle, drugs can be loaded inside nanoparticles that can carry the drug through the BBB. However, not all particles are able to cross the BBB and a multitude of factors needs to be taken into account when developing a carrier system for this purpose. Depending on the chosen pathway to cross the BBB, nanoparticle material, size and surface properties such as functionalization and charge should be tailored to fit the specific route of BBB crossing.

1 September 2007 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
NNNoha Nafee
Noha Nafee
STSebastian Taetz
Sebastian Taetz
Marc SchneiderMarc Schneider
Marc Schneider
USUlrich F. Schaefer
Ulrich F. Schaefer
CLClaus-Michael Lehr
Claus-Michael Lehr

3 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JKJulian Kirch
Julian Kirch
ASAndreas Schneider
Andreas Schneider
BABérengère Abou
Bérengère Abou
AHAlexander Hopf
Alexander Hopf
USUlrich F. Schaefer
Ulrich F. Schaefer
CLClaus-Michael Lehr
Claus-Michael Lehr
In this study, the mobility of nanoparticles in mucus and similar hydrogels as model systems was assessed to elucidate the link between microscopic diffusion behavior and macroscopic penetration of such gels. Differences in particle adhesion to mucus components were strongly dependent on particle coating. Particles coated with 2 kDa PEG exhibited a decreased adhesion to mucus components, whereas chitosan strongly increased the adhesion. Despite such mucoinert properties of PEG, magnetic nanoparticles of both coatings did not penetrate through native respiratory mucus, resisting high magnetic forces (even for several hours). However, model hydrogels were, indeed, penetrated by both particles in dependency of particle coating, obeying the theory of particle mobility in an external force field. Comparison of penetration data with cryogenic scanning EM images of mucus and the applied model systems suggested particularly high rigidity of the mucin scaffold and a broad pore size distribution in mucus as reasons for the observed particle immobilization. Active probing of the rigidity of mucus and model gels with optical tweezers was used in this context to confirm such properties of mucus on the microscale, thus presenting the missing link between micro- and macroscopical observations. Because of high heterogeneity in the size of the voids and pores in mucus, on small scales, particle mobility will depend on adhesive or inert properties. However, particle translocation over distances larger than a few micrometers is restricted by highly rigid structures within the mucus mesh.

1 October 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
NNNoha Nafee
Noha Nafee
AHAyman Husari
Ayman Husari
CMChristine K. Maurer
Christine K. Maurer
CLCenbin Lu
Cenbin Lu
CRChiara de Rossi
Chiara de Rossi
Marc SchneiderMarc Schneider
Marc Schneider